Dr. Lal PathLabs Limited (BOM:539524)

India · Delayed Price · Currency is INR

3,189.30

-22.35 (-0.70%)

At close: Aug 8, 2025

Dr. Lal PathLabs Employees

Dr. Lal PathLabs had 4,980 employees as of March 31, 2025. The number of employees increased by 881 or 21.49% compared to the previous year.

Employees

4,980

Change (1Y)

881

Growth (1Y)

21.49%

Revenue / Employee

5.08M INR

Profits / Employee

1.03M INR

Market Cap

266.42B

Employees Chart

Employees History

Date	Employees	Change	Growth
Mar 31, 2025	4,980	881	21.49%
Mar 31, 2024	4,099	51	1.26%
Mar 31, 2023	4,048	-62	-1.51%
Mar 31, 2022	4,110	114	2.85%
Mar 31, 2021	3,996	73	1.86%
Mar 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
Reliance Industries	403,303
HDFC Bank	214,521
Bharti Airtel	13,593
Tata Consultancy Services	607,979
ICICI Bank	182,665
State Bank of India	236,226
Infosys	323,578
Hindustan Unilever	18,802

Employee Rankings

Dr. Lal PathLabs News

6 weeks ago - Dr Lal PathLabs, Metropolis Healthcare shares decline as Amazon Diagnostics enters market - Business Upturn
6 weeks ago - Dr Lal PathLabs shares decline 2% as Amazon enters diagnostics segment with doorstep lab tests - Business Upturn
3 months ago - Dr. Lal PathLabs Q4 FY25: Revenue up 10.48% to 602.6 crore, Net profit surges 81% YoY - Business Upturn
10 months ago - Dr Lal Path Labs stock jumps 3.46% after strong Q2 earnings and positive brokerage calls - Business Upturn
10 months ago - Dr Lal Path Labs share price: Buy, Sell, or Hold? Check what brokerages are saying - Business Upturn
10 months ago - UBS maintains buy call on Dr LalPath Labs, expects 7.7% upside in share price - Business Upturn
10 months ago - Dr Lal PathLabs Q2 FY25: Revenue up 9.8% YoY to ₹660.2 crore, net profit rises 18.1% YoY to ₹130.8 crore - Business Upturn